Dr. Benjamin Farahnik, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $13,350 | 6 | 54.8% |
| Food and Beverage | $10,889 | 442 | 44.7% |
| Travel and Lodging | $121.27 | 3 | 0.5% |
| Education | $15.27 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $14,633 | 33 | $0 (2024) |
| ABBVIE INC. | $2,166 | 95 | $0 (2024) |
| GENZYME CORPORATION | $1,286 | 31 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $687.04 | 20 | $0 (2024) |
| UCB, Inc. | $683.61 | 69 | $0 (2024) |
| Janssen Biotech, Inc. | $572.18 | 23 | $0 (2024) |
| LEO Pharma Inc. | $566.11 | 23 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $553.17 | 20 | $0 (2024) |
| Lilly USA, LLC | $480.95 | 18 | $0 (2024) |
| PFIZER INC. | $396.80 | 32 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19,044 | 216 | Amgen Inc. ($14,396) |
| 2023 | $3,199 | 156 | ABBVIE INC. ($682.12) |
| 2022 | $1,630 | 69 | ABBVIE INC. ($477.50) |
| 2021 | $130.60 | 6 | AbbVie Inc. ($35.14) |
| 2020 | $137.20 | 3 | AbbVie Inc. ($137.20) |
| 2019 | $112.49 | 1 | Galderma Laboratories, L.P. ($112.49) |
| 2018 | $122.52 | 1 | Regeneron Healthcare Solutions, Inc. ($122.52) |
All Payment Transactions
452 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $31.15 | General |
| Category: Immunology | ||||||
| 12/26/2024 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| Category: Inflammation | ||||||
| 12/26/2024 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: Inflammation | ||||||
| 12/23/2024 | Amgen Inc. | Otezla (Drug) | Travel and Lodging | Cash or cash equivalent | $48.24 | General |
| Category: Inflammation | ||||||
| 12/18/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: Immunology | ||||||
| 12/18/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: DERMATOLOGY | ||||||
| 12/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Immunology | ||||||
| 12/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $2.89 | General |
| Category: Immunology | ||||||
| 12/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $1.16 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $142.76 | General |
| Category: Inflammation | ||||||
| 12/17/2024 | Amgen Inc. | Otezla (Drug) | Travel and Lodging | Cash or cash equivalent | $48.24 | General |
| Category: Inflammation | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $86.62 | General |
| Category: Immunology | ||||||
| 12/16/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Inflammation & Immunology | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $9.27 | General |
| Category: Immunology | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $2.73 | General |
| Category: Immunology | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $1.59 | General |
| Category: Immunology | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $0.36 | General |
| Category: Immunology | ||||||
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $46.89 | General |
| Category: Immunology | ||||||
| 12/06/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.66 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $28.33 | General |
| Category: Dermatology | ||||||
| 12/02/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Dermatology | ||||||
| 11/22/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $20.60 | General |
| 11/21/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $29.59 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,160 | 10,197 | $631,176 | $260,463 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 401 | 678 | $87,401 | $50,080 | 57.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 220 | 331 | $63,299 | $33,982 | 53.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 136 | 199 | $91,270 | $29,103 | 31.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 207 | 289 | $52,435 | $28,450 | 54.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 340 | 483 | $71,987 | $21,163 | 29.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 190 | 228 | $40,140 | $17,183 | 42.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 287 | 1,970 | $68,649 | $12,030 | 17.5% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 22 | 28 | $21,650 | $10,401 | 48.0% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 29 | 40 | $18,483 | $10,212 | 55.3% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 21 | 5,600 | $16,630 | $6,947 | 41.8% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 13 | 15 | $16,008 | $6,319 | 39.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 57 | 57 | $10,920 | $5,005 | 45.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $11,240 | $4,941 | 44.0% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 32 | 40 | $17,811 | $4,392 | 24.7% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 16 | 16 | $8,955 | $4,318 | 48.2% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 11 | 12 | $8,620 | $4,298 | 49.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 56 | 76 | $7,238 | $3,469 | 47.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 20 | 21 | $4,662 | $2,408 | 51.7% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 13 | 15 | $7,047 | $1,698 | 24.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 28 | 32 | $2,506 | $1,544 | 61.6% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 12 | 17 | $2,169 | $1,301 | 60.0% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 11 | 12 | $2,053 | $1,221 | 59.5% |
About Dr. Benjamin Farahnik, MD
Dr. Benjamin Farahnik, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Long Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2017. The National Provider Identifier (NPI) number assigned to this provider is 1699209254.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benjamin Farahnik, MD has received a total of $24,376 in payments from pharmaceutical and medical device companies, with $19,044 received in 2024. These payments were reported across 452 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($13,350).
As a Medicare-enrolled provider, Farahnik has provided services to 2,160 Medicare beneficiaries, totaling 10,197 services with total Medicare billing of $260,463. Data is available for 1 year (2023–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Clinical & Laboratory Dermatological Immunology
- Location Long Beach, CA
- Active Since 04/20/2017
- Last Updated 02/15/2022
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1699209254
Products in Payments
- Otezla (Drug) $14,604
- DUPIXENT (Biological) $1,722
- SKYRIZI (Biological) $912.04
- RINVOQ (Biological) $834.92
- ADBRY (Biological) $566.11
- Sotyktu (Drug) $553.17
- TREMFYA (Drug) $529.02
- TALTZ (Drug) $405.95
- Bimzelx (Biological) $365.95
- COSENTYX (Drug) $323.51
- OPZELURA (Drug) $251.28
- EUCRISA (Drug) $216.15
- Cimzia (Drug) $185.12
- CIBINQO (Drug) $180.65
- SPEVIGO (Drug) $170.27
- HUMIRA (Biological) $150.04
- VTAMA (Drug) $135.50
- LIBTAYO (Biological) $128.27
- DUPIXENT DUPILUMAB INJECTION (Biological) $122.52
- EPIDUO FORTE (Drug) $112.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Long Beach
David Tahour, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $241,250
Dr. Ryan Chandhoke, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $25,345
Dr. Elinor Lin, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $21,438
Dr. Ron Sklash, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $20,796
Stephanie Tran, Od, Ms, OD, MS
Student in an Organized Health Care Education/Training Program — Payments: $14,495
David Nguyen
Student in an Organized Health Care Education/Training Program — Payments: $13,438